Burzynski Research Institute, Inc.Share · US1231591058 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Burzynski Research Institute, Inc.
No Price
Closing Price OTC 01.05.2026:
0,02 USD
01.05.2026 19:16
Current Prices from Burzynski Research Institute, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
BZYR
USD
01.05.2026 19:16
0,02 USD
0,001 USD
+9,00 %
Company Profile for Burzynski Research Institute, Inc. Share
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. The company is also involved in the production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.
